...“That’s a tremendous asset to a firm like ours. He’s very comfortable with working big deals out.” Those deals might be with Pfizer, IBM or Louis Vuitton, all BGR clients. Mantz – and his bulging Rolodex – will work with private sector businesses as well...

...for ophthalmic and glaucoma alike, and the global market is about 2-3 times that of the US market. Alcon, Allergan, Merck and Pfizer are main players. The report focuses on glaucoma as a major ophthalmic market. The various aspects of glaucoma are discussed...

...will be granted. The June 2011 expiration date includes a six-month extension of the original expiration date granted because Pfizer did research after the drug was approved to determine its safety and effectiveness in children — a standard move by drug companies...

...of new drugs. What happens when that pipeline goes dry? Obviously, the company is not worth as much. That has been the situation at Pfizer (NYSE: PFE). During the last five years, we have been hearing about a dwindling drug pipeline with no sign of abating....

...information on the labels of the smoking-cessation product Champix. In a statement Tuesday, it said it's working with the drugmaker Pfizer to update prescribing information after reports of serious psychiatric symptoms associated with the use of Champix....

...of the world's foremost companies, including Abbott Laboratories, BASF, Clorox, ExxonMobil, Goodyear, GE, Kellogg, Nestle, PepsiCo, Pfizer, Procter & Gamble, Toyota, and Unilever. SAILS, INSIGHT's award-winning flagship product, can accurately represent a...

...and CEO of CombinatoRx, Reinhard Ambros and Simon Campbell, Ph.D. Former SVP, Worldwide Discovery and Medicinal R&D Europe, Pfizer. FORMA Therapeutics is integrating transformative biology and chemistry to unlock the best targets and pathways that genomics...

...in 2011. Amgen would bring biotech manufacturing capacity along with some big drugs, Cramer points out. Gilead would help Pfizer push further into the HIV market. BMS would help with cancer and HIV. Wyeth has a big vaccines business and biologic manufacturing...

...the Phase 2b trial for Peyronie's disease. In addition, Auxilium just announced a major European licensing agreement with Pfizer, in which BioSpecifics will receive a share of both the upfront payment and sales and regulatory milestones. We are very much looking...

...Although some physicians use misoprostol to induce labor, it is not approved for that use, the Times reports. A spokesperson for Pfizer, which manufactures Cytotec, said the company does not support the off-label use of the drug to induce abortion, adding...